Edwards Lifesciences (EW) Free Cash Flow (QoQ) (2009 - 2026)
Edwards Lifesciences (EW) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,872.51% |
| Mar 31, 2026 | -105.97% |
| Dec 31, 2025 | -31.52% |
| Sep 30, 2025 | 114.28% |
| Jun 30, 2025 | 7.35% |
| Mar 31, 2025 | 226.57% |
| Dec 31, 2024 | -159.12% |
| Sep 30, 2024 | 4.82% |
| Jun 30, 2024 | 340.82% |
| Mar 31, 2024 | -345.96% |
| Dec 31, 2023 | -86.44% |
| Sep 30, 2023 | 2,590.91% |
| Jun 30, 2023 | -105.66% |
| Mar 31, 2023 | 18.09% |
| Dec 31, 2022 | -14.44% |
| Sep 30, 2022 | -13.52% |
| Jun 30, 2022 | 31.05% |
| Mar 31, 2022 | -22.27% |
| Dec 31, 2021 | -39.77% |
| Sep 30, 2021 | 3.15% |